1174 related articles for article (PubMed ID: 31381464)
1. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.
Key NS; Khorana AA; Kuderer NM; Bohlke K; Lee AYY; Arcelus JI; Wong SL; Balaban EP; Flowers CR; Francis CW; Gates LE; Kakkar AK; Levine MN; Liebman HA; Tempero MA; Lyman GH; Falanga A
J Clin Oncol; 2020 Feb; 38(5):496-520. PubMed ID: 31381464
[TBL] [Abstract][Full Text] [Related]
2. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.
Key NS; Khorana AA; Kuderer NM; Bohlke K; Lee AYY; Arcelus JI; Wong SL; Balaban EP; Flowers CR; Gates LE; Kakkar AK; Tempero MA; Gupta S; Lyman GH; Falanga A
J Clin Oncol; 2023 Jun; 41(16):3063-3071. PubMed ID: 37075273
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
Lyman GH; Khorana AA; Kuderer NM; Lee AY; Arcelus JI; Balaban EP; Clarke JM; Flowers CR; Francis CW; Gates LE; Kakkar AK; Key NS; Levine MN; Liebman HA; Tempero MA; Wong SL; Prestrud AA; Falanga A;
J Clin Oncol; 2013 Jun; 31(17):2189-204. PubMed ID: 23669224
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.
Lyman GH; Bohlke K; Khorana AA; Kuderer NM; Lee AY; Arcelus JI; Balaban EP; Clarke JM; Flowers CR; Francis CW; Gates LE; Kakkar AK; Key NS; Levine MN; Liebman HA; Tempero MA; Wong SL; Somerfield MR; Falanga A;
J Clin Oncol; 2015 Feb; 33(6):654-6. PubMed ID: 25605844
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants.
Ay C; Beyer-Westendorf J; Pabinger I
Ann Oncol; 2019 Jun; 30(6):897-907. PubMed ID: 30918939
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
[TBL] [Abstract][Full Text] [Related]
10. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
Wang Y; Wang M; Ni Y; Liang Z
Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
[No Abstract] [Full Text] [Related]
11. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
12. Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology.
Verso M; Di Nisio M
Eur J Intern Med; 2020 Jan; 71():4-7. PubMed ID: 31732452
[TBL] [Abstract][Full Text] [Related]
13. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
Zhu J; Jiang H; Marshall B; Li J; Tang X
Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis.
Lyman GH; Kuderer NM
Thromb Res; 2020 Jul; 191 Suppl 1():S79-S84. PubMed ID: 32736784
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
16. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients.
Bhalla V; Abdel-Latif A; Bhalla M; Ziada K; Williams MV; Smyth SS
Am J Cardiol; 2018 Oct; 122(7):1236-1243. PubMed ID: 30082040
[TBL] [Abstract][Full Text] [Related]
18. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis.
Xin Z; Liu F; Du Y; Mao F; Wang X; Xu P; Li Z; Qian J; Yao J
Ann Palliat Med; 2020 Sep; 9(5):2970-2981. PubMed ID: 32787358
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis.
Chen H; Tao R; Zhao H; Jiang J; Yang J
Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
